Celldex Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $6.3M | 158k | 39.67 |
| 2023-09-30 | $583k | 21k | 27.52 |
| 2023-06-30 | $26k | 777 | 33.93 |
| 2023-03-31 | $2.2M | 61k | 35.98 |
| 2022-12-31 | $5.3M | 119k | 44.57 |
| 2022-09-30 | $1.0M | 37k | 27.63 |
| 2022-06-30 | $3.1M | 114k | 26.95 |
| 2022-03-31 | $5.4M | 161k | 33.64 |
| 2021-12-31 | $5.0M | 131k | 38.35 |
| 2021-09-30 | $2.6M | 47k | 53.99 |
| 2021-06-30 | $678k | 20k | 33.39 |
| 2021-03-31 | $1.1M | 55k | 20.61 |
| 2020-12-31 | $48k | 2.8k | 17.53 |
| 2020-09-30 | $23k | 1.6k | 14.68 |
| 2020-06-30 | $7.2k | 590 | 12.20 |
| 2020-03-31 | $1.1k | 897 | 1.21 |
| 2019-12-31 | $0 | 1.5k | 0.00 |
| 2019-09-30 | $0 | 4.7k | 0.00 |
| 2019-06-30 | $17k | 3.5k | 4.98 |
| 2019-03-31 | $1.0k | 201 | 4.98 |